Featured Story

FDA gives scientists freedom to tweet in long-awaited social media policy

The regulator, which has faced criticism in the past over its failure to establish a policy, set out its position in a 12-page document.

Amazon shares landmark cancer genome data sets on cloud platform

Amazon has made The Cancer Genome Atlas and The International Cancer Genome Consortium PanCancer data sets freely available through its cloud platform. The addition of the data sets continues Amazon's push to differentiate its cloud offering through the availability of data.

Illumina to make 5,000-genome autism database available through BaseSpace

Illumina is to make a 5,000-genome autism database available through BaseSpace. The deal will enable researchers to analyze the genomes of people with autism and their families using tools built into Illumina's cloud computing platform.

Molecular Health raises $27M to advance data-crunching tech

Molecular Health has raised $27 million to drive adoption of its data-crunching technology, which includes a tool aimed at drug developers. The investment moves the sum raised by Molecular Health to date beyond the $100 million mark.

Andreessen Horowitz places $200M bet on the confluence of IT and biotech

The Silicon Valley biotech investment scene just gained another major player: Andreessen Horowitz. And with $200 million to spend and a plan to place three to four small bets each quarter, the VC shop has the potential to help numerous life science IT startups get up and running.